cgp 28392 has been researched along with cardiovascular agents in 1 studies
Studies (cgp 28392) | Trials (cgp 28392) | Recent Studies (post-2010) (cgp 28392) | Studies (cardiovascular agents) | Trials (cardiovascular agents) | Recent Studies (post-2010) (cardiovascular agents) |
---|---|---|---|---|---|
76 | 1 | 2 | 17,645 | 1,480 | 6,891 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jonkman, FA; Korstanje, C; Van Kemenade, JE; Van Zwieten, PA | 1 |
1 other study(ies) available for cgp 28392 and cardiovascular agents
Article | Year |
---|---|
Bay k 8644, a calcium entry promoter, as an antidote in verapamil intoxication in rabbits.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; 4-Aminopyridine; Aminopyridines; Animals; Antidotes; Atrioventricular Node; Blood Pressure; Cardiovascular Agents; Electrocardiography; Female; Heart Rate; Hydrogen-Ion Concentration; In Vitro Techniques; Ion Channels; Male; Pyridines; Rabbits; Verapamil | 1987 |